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Summary
This study has identified a single amino acid change in the viral glycoprotein that profoundly
affects the ability of lymphocytic choriomeningitis virus (LCMV) to persist in its natural host .
Adult immunocompetent mice infected with a variant--of the Armstrong strain, spleen isolate
clone 13 (svA/svA), harbor virus for several months and exhibit suppressed T cell responses .
In contrast, adult mice infected with a reassortant virus (svA/wtA) that contains the L segment
of the spleen variant and the S segment of the parental wt Armstrong, make potent LCMV
specific CTL responses and clear the infection within 2-4 wk . These two viruses, spleen variant
clone 13 and the reassortant svA/wtA, are identical in their noncoding regions and show no
amino acid changes in any of their viral genes except for one substitution in the glycoprotein .
The reassortant virus svA/wtA has a phenylalanine at amino acid residue 260 of the glycoprotein,
whereas the spleen variant clone 13 has a leucine at this position . This study constitutes one
of the first reports defining the genetic basis of viral persistence at the whole animal level, and
identifying a single mutation that markedly increases the ability of a virus to persist in its natural host .
S
uccessful resolution of a viral infection depends upon a
critical balance between the extent ofviral spread and repli-
cation, and the magnitude of the host's immune response.
We have been studying infection of mice with lymphocytic
choriomeningitis virus (LCMV)t as a model system to un-
derstand the host and viral determinants that lead to viral
clearance or persistence (1-4) . Infection of immunocompe-
tent adult mice with the Armstrong strain ofLCMV induces
a potent antiviralT cellresponse and virus is eliminated within
2 wk . This clearance is mediated by CD8 * virus-specific
cytotoxicT lymphocytes (4-7) . In contrast, infection ofadult
mice with a naturally selected isolate of Armstrong, spleen
variant clone 13, results in a disseminated infection, with virus
persisting for several months (1, 2) . This chronic infection
is associated with suppressed T cell responses and suscepti-
bility to opportunistic infection (1, 2, 8) .
The LCMV genome consists oftwo segments of single-
stranded RNA, a large (L) segment of 7.2 kb and a small
(S) segment of 3.4 kb (9-12) . The L RNA segment codes
for a large protein, L (molecular mass 250 kD), that is be-
1 Abbreviations used in this paper. L, large; LCMV, lymphocytic
choriomeningitis virus; S, small; sv, spleen variants; wt, wild type.
lieved to be the viral polymerase, and also contains a second
open reading frame, designated Z, that encodes for a protein
of"10-12 kD. The S segment codes for the three major struc-
tural proteins : the internal nucleocapsid protein (NP ; 63 kD)
and the two surface glycoproteins GP-1 (43 kD) and GP-2
(36kD) that are derived from a common precursor polypep-
tide, GP-C. After coinfwtion of cells with two differentLCMV
strains, recombinants are generated by reassortment of ge-
nome segments. This permits genetic analysis of LCMV
pathogenicity (9, 13) .
In this study, we have made reassortants between the pa-
rental Armstrong strain and the spleen variant clone 13 and
examined their biological properties. Using this genetic ap-
proach in combination with complete sequence analysis of
the S segment, we show that a single amino acid change in
the viral glycoprotein profoundly affects the ability ofLCMV
to persist in adult mice.
Materials and Methods
Mice
￿
4-6-wk-old BALB/cByJ mice purchased from TheJackson
Laboratory (Bar Harbor, ME) were used in all experiments .
Virus.
￿
The origins of the Armstrong CA1371, Pasteur CIPV
76001, andtheTraub strains ofLCMV used in this study have been
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the spleen of an 8-wk-old BALB/cLCMV carrier mouse infected
at birth with strain ArmstrongCA1371 . The laboratory virus stocks
ofthe Armstrong, Pasteur andTraub strains ofLCMV are referred
to as wild type (wt) . All LCMV stocks used in this study (wt,
spleen variant clone 13, and the reassortants) were triple plaque
purified on Vero cells, andthen stocks were grown in BHK-21 cells .
Virus stocks at the passage 1 or 21evel were used in all experiments .
Generation ofReassortants.
￿
Coinfection ofBHK-21 cells and the
procedures used to screen the progeny for reassortants were as pre-
viously described (2).
Determination ofVirus Titers.
￿
InfectiousLCMV was quantitated
by plaque assayon Vero cell monolayers as previously described (1) .
CTL Assay.
￿
LCMVspecific CTL activities in spleens andlymph
nodes were determined by a 6-h "Cr-release assay as previously de-
scribed (1) .
Sequence Analysis.
￿
Thecomplete Ssegment ofthe parental Arm-
strong strain and spleen variant clone 13 wassequencedby the primer
extension method using virus specific oligonucleotides (14). Either
1-3 Pg of viralRNA extracted from purified virus or 50 ug of
total infected cell RNA was used for the sequencing reactions .
Results
Generation ofReassortants between wt Armstrong and Arm-
strong Spleen Variant Clone 13 . The Armstrong spleen vari-
ants (sv) cannot be distinguished from the parental wild type
(wt) Armstrong virus either by reactivity to apanelofmAbs
or on the basis of hybridization with wt Armstrong-specific
cDNA probes (2 ; and our unpublisheddata) . However, the
Armstrong-specific cDNA probes can differentiate between
Armstrong and otherLCMV strains such as the Pasteur strain
Table 1 .
￿
Strategy Used for Making Reassortant between
Parental Wild Type Armstrong (wtA) and Armstrong Spleen
Variant Clone 13 (svA)
' The cross was done between two reassortants svA/wtP andwtT/wtA.
The following notation is used to indicate the genotype : svA/wtP indi-
cates a reassortant with L segment of spleen variant Armstrong and S
segment of wt Pasteur; and wtT/wtA indicates a reassortant with L seg-
ment of wt Traub and S segment of wt Armstrong .
t The genotypes of the four possible progeny clones (the two parents
and the two reassortants) can be identified by their characteristic reac-
tivity pattern with Armstrong-specific Land ScDNA probes . Thus, the
desired reassortant, svA/wtA, containing the L segment of spleen vari-
ant Armstrong and S segment of wt Armstrong can be easily identified .
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andthe Traub strain (2, 15). Therefore, the strategy outlined
in Table 1 was used to make reassortants between the pa-
rental wt Armstrong (wtA/wtA ; this notation indicates L
segmentofwt Armstrong and S segment ofwt Armstrong)
and theArmstrong spleen variant clone 13 (svA/svA). Briefly,
reassortants were first made between Armstrongclone 13 and
Pasteur, and wt Armstrong and Traub, and then these reas-
sortants were crossed to obtain the desired virus. Table 1
describes the cross that was done to obtain the reassortant
svA/wtA (L segment of sv Armstrong and S segment ofwt
Armstrong), and the data showing the expected hybridiza-
tion patterns are shown in Fig. 1 .
Sequence Comparison between Spleen Isolate Clone 13 (svA/svA)
and the Reassortant svA/wtA . The spleen variant clone 13
(svA/svA) and the reassortant svA/wtA share a common L
segment (derived from clone 13)but contain different S seg-
ments. To determinethe precise location ofthegenetic differ-
ences between these two viruses their S segments were se-
quenced by the primer extension technique as described in
Materials and Methods . Sequence analysis of the S segments
of the two viruses revealed only two nucleotide differences
between the parental wt Armstrong and its spleen variant
clone 13 . Therewere no changes in the nucleoprotein gene,
and only two changes (at nucleotide positions 855 and 1298)
in the glycoprotein (GP-C) gene . Both of these were U -->
C changes ; the one at position 855 resulted in a phenylala-
nine -> leucine change, whereas the one at residue 1298 was
a silent one (see Figure 2) . These findings are in agreement
with the resultsofSalvato et al . whohad previously sequenced
the complete S segment of clone 13 (16) . Thus, our results
show that the spleen variant clone 13 (svA/svA) andthe reas-
Figure 1 .
￿
Identification ofreas-
sortant containing L segment of
Armstrong spleen variant clone 13
and S segment of parental wt
Armstrong(svA/wtA genotype) .
Refer to Table 1 for details of the
cross done to obtain the svA/wtA
reassortant . Total RNA was ex-
tracted from infected BHK-21 cells
by the guanidinium thiocya-
nate-CsCl procedure. The RNA
samples were denatured with
formaldehyde, and 5.0jig ofRNA
dotted onto nitrocellulose paper
with a 96-hole Bio-Dot apparatus .
The filter was hybridized with
32P-labeled cDNA probes specific
for the L and S segments of the
wt Armstrong strain . (Lane 1)
Reassortant wtT/wtA showing
no hybridization with theLprobe
but positive hybridization with
the S probe ; (lane 2) reassortant svA/wtP showing positive signal with
theL probe but no hybridization with the S probe ; (lanes 3-S) three progeny
clones with thesvA/wtA genotype showing positive hybridization with
both L and S probes .
Reactivity with
specific cDNA
Armstrong-
probes$
Cross; Progeny clonest L specific S specific
svA/wtP svA/wtP + -
x wtT/wtA - +
wtT/wtA wtT/wtP - -
svA/wtA +Figure2 .
￿
Identification ofsequence differences between the S segments
of parental wt Armstrong (wtArm) and spleen variant clone 13 (svArm) .
The phenylalanine to leucine change seen in svArm is close to the putative
proteolytic cleavage site (RR) of the viral glycoprotein (19) .
sortant (svA/wtA) are identical in all genesexcept for a single
amino acid change in the glycoprotein . There were also no
nucleotide differences between these two viruses (clone 13
and svA/wtA) in the noncoding regions .
Biological Studies with the Reassortants.
￿
The spleen isolate
clone 13 and the reassortant svA/wtA were tested for their
ability to induce LCMVspecific CTL responses and to cause
persistent infections in adult BALB/c mice. The parental wt
Armstrong virus was also included in these experiments. As
shown in Table 2 spleen isolate clone 13 caused a persistent
infection in adult mice and high levels of virus were present
in several tissues tested . In contrast, the reassortant svA/wtA,
which differs from clone 13 by only a single amino acid in
the glycoprotein, was eliminated from most tissues by day
15 andfrom allorgans tested by day 30 post-infection . Also,
the amount ofsvA/wtA present in tissues and serum ofmice
8 d post-infection was 100-1,000-fold lower than the level
ofclone 13 . These results clearly show the biological impor-
tanceof the Phe-Leuchange in the viral glycoprotein . This
conclusion is furtherstrengthened by theLCMVspecific CTL
Table 2.
￿
Viral Persistence in Adult Mice
Day 8 post-infection
Virus genotype
(L/S segment)
￿
Serum Spleen Lung Liver
wtA/wtA <1.6 <2.6
svA/svA 5 .9 6.4
svA/wtA 3.5 4.1
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Table 3.
￿
LCMV-speck CTL Response o .%Adult mice
Percent specific "Cr release from
BALB C17 (H-2d) targets at
E/T ratios of:
Adult BALB/c mice were infected intravenously with 106 PFU of the
indicated virus and CTL response in the spleen checked at 8 d post-
infection .
data shown in Table 3 . Adult mice infected with clone 13
contained low levels of LCMVspecific CTL in the spleen,
whereas mice infected with svA/wtA contained high levels
of antiviral CTL activity.
Our previous studies have shown that genetic changes in
theLsegment contribute to the clone 13 phenotype(2) . The
data shown in Tables 2 and 3 also suggest this since the reas-
sortant svA/wtA was not exactly like the parental wt Arm-
strong virus (wtA/wtA). The level ofsvA/wtA virus at 8 d
post-infection was 10-100-fold higher than that ofwtA/wtA.
Also, theCTL response induced by wtA/wtA was slightly
LCMV titer (logla PFU/organ or ml)*
Day 15 post-infection
￿
Day 30 post-infection
Serum Spleen Lung Liver Brain Serum Spleen Lung Liver Brain
2 .8 <2.6 <2 .6 <1 .6 <2.6 <2 .6 <2.6 <2.6 <1 .6 <2.6 <2.6 <2.6 <2.6
7.1 7.5 5.7 5.7 5 .8 6.4 6.3 6.2 4.4 4.7 6.0 5.8 6.0
4.0 4.9 3 .9 <1 .6 <2.6 2.6 <2.6 3.0 <1 .6 <2.6 <2.6 <2.6 <2.6
Adult BALB/c mice were infected intravenously with 106 PFU of the indicated virus .
* Mice were killed and the virus titer in the various organs and serum was determined by a plaque assay on Vero cells. The data shown are the
average of four to six mice per group at each time point .
Virus genotype
(L/S segment)
Mouse
No .
LCMV infected
5.5 :1 16.6 :1 50:1
Uninfected
50:1
wtA/wtA 1 33 58 83 3
2 40 70 84 11
3 27 50 81 5
svA/svA 1 0 0 4 4
2 2 6 20 1
3 0 3 11 0
svA/wtA 1 14 49 62 0
2 16 47 64 0
3 10 40 59 2more (N2-fold higher in lytic unitsApleen) than that seen
in svA/wtAinfected mice . To further confirm these observa-
tions we made the reciprocal reassortant wtAAvA and tested
its biological properties . As shown in Table 4, the reassor-
tant wtA/svA was unable to cause a chronic infection in adult
mice and induced a potent LCMVspecific CTL response .
These results confirm our earlier findings andshow unequivo-
cally that biologically relevant mutation(s) have also occurred
in the L segment of spleen variant clone 13 (2) . The data
in Table 4 also re-emphasize the significance of the Phe -
Leu mutation in the S segment ; the reassortantwtAAvA was
present at higher levels (>20-fold) in the serum at day 8 com-
pared with the wt Armstrong, and the CTL response in
wtAAvA infected mice was -2-fold lower (in lytic units/
spleen) than the response of wtA/wtA infected mice .
Discussion
The main finding of this study is the identification of a
single amino acid change in the viral glycoprotein that pro-
foundly affects the ability ofLCMV to persist in adult mice.
We have compared the biological properties of two viruses,
LCMV spleen isolate clone 13 (svA/svA) and the reassortant
svA/wtA, that are identical in their noncoding regions and
show no amino acid changes in any of their viral genes ex-
cept for one substitution in the glycoprotein . Our results show
that mice infected with clone 13 (leucine at amino acid res-
idue 260 of glycoprotein) contained low levels of LCMV-
specific CTL in the spleen and were unable to clear the vi-
rus, whereas mice infected with the reassortant svA/wtA
(phenylalanine at residue 260) exhibited high levels ofLCMV
specific CTL and the infection was cleared within 2-4 wk.
The spleen isolate clone 13 also contains a second change
in the glycoprotein gene at nucleotide residue 1298 (see Fig.
2) . Although the contribution of this mutation to the clone
13 phenotype cannot be completely ruled out, it is highly
Table 4.
￿
Biological Characterization of Reassortant wtA/svA
LCMV-specific CTL in spleens
Percent specific "Cr release from BALB C17 (H-2d)
targets at E/T ratio of:
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unlikely since this nucleotide change is a silent one that does
not alter the amino acid sequence. Moreover, our prelimi-
nary results show that this silent U - C change at residue
1298 is not found in other spleen isolates that are biologi-
cally similar to clone 13 . In contrast, the U --" C change
at position 855 that results in the Phe - Leu mutation is
present in all LCMV spleen isolates that show the clone 13
phenotype (Ahmed, R ., et al ., unpublished data) .
The spleen variant clone 13 was isolated from mice origi-
nally infected with the parental wt Armstrong virus (1) . Thus,
the results of this study provide unequivocal proof that the
naturally selected Phe -" Leu mutation is biologically rele-
vant . We have preliminary data suggesting that this Phe -
Leu mutation allows enhanced growth within lymphoid tissue
(Matloubian, M ., and R . Ahmed, unpublished data) . This
enhanced growth capability in cells of the immune system
is a likely explanation for the ability of the spleen variant
to establish a chronic infection in adult mice. The observed
Phe- Leu change is not within any of the CTL epitopes
that have been mapped (17, 18) ; therefore, it is unlikely that
the low level ofLCMVspecific CTL response detectable in
clone 13 infected mice is due to altered recognition ofCTL
epitopes . It is more likely that this low CTL phenotype is
the result ofincreased growth in lymphoid tissue and greater
dissemination ofthe virus . In this context, it is worth noting
that the Phe -> Leu mutation is close to the putative cleavage
site of the viral glycoprotein (Fig . 2 ; reference 19) . Proper
proteolytic cleavage is essential for infectivity, and alterations
in the processing of the viral glycoprotein are likely to affect
the growth rate of the virus . Experiments are currently in
progress to determine if this Phe- Leu change affects either
the site or rate of cleavage of the viral glycoprotein .
The results of this study also confirm our earlier findings
that biologically relevant mutation(s) occurred on the L seg-
ment during the wt Armstrong to clone 13 transition (2) .
Thus, the complete clone 13 phenotype is due to the Phe
LCMV titer in serum
(log,o PFU/ml)S
' Adult BALB/c mice were infected intravenously with 106 PFU of the indicated virus .
s CTL response was checked 8 d post-infection . The data shown are the average of three mice per group .
S Mice were eye-bled at the indicated times and titer of infectious LCMV in the serum was determined by a plaque assay on Vero cells . The data
shown are the average of three to six mice per group .
Virus genotype"
(L/S segment) 5.5 :1
LCMV infected
16.6 :1 50:1
Uninfected
50:1 8
Days post-infection
15 30
wtA/wtA 31 57 85 4 <1 .6 <1.6 <1.6
svA/svA 3 6 11 4 5 .6 5.0 4.6
wtA/svA 23 43 67 2 3 .1 <1.6 <1.6-" Leu change in the glycoprotein and additional mutation(s)
in the L segment . Studies are in progress to identify these
changes in the L segment .
Viral determinants of pathogenicity have been identified
in many different viruses, and in some instances changes in
virulence have been linked to single amino acid or nucleotide
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